High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model.

High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model.

Item
http://www.wikidata.org/entity/Q34415673
Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic studyPsychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actionsBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.PsychedelicsEffects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.Indolealkylamines: biotransformations and potential drug-drug interactionsTowards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activationPotentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 statusModification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitorDevelopment of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.Synthesis and structure evaluation of new complex butylarylpiperazin-1-yl derivatives.Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.Biological Effects and Biodistribution of Bufotenine on Mice.The Development of Toad Toxins as Potential Therapeutic Agents
P2860

High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model.

Item
http://www.wikidata.org/entity/Q34415673
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
High-affinity agonist binding ...... odified ternary complex model.
@ast
High-affinity agonist binding ...... odified ternary complex model.
@en
High-affinity agonist binding ...... odified ternary complex model.
@nl
type
label
High-affinity agonist binding ...... odified ternary complex model.
@ast
High-affinity agonist binding ...... odified ternary complex model.
@en
High-affinity agonist binding ...... odified ternary complex model.
@nl
prefLabel
High-affinity agonist binding ...... odified ternary complex model.
@ast
High-affinity agonist binding ...... odified ternary complex model.
@en
High-affinity agonist binding ...... odified ternary complex model.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
High-affinity agonist binding ...... odified ternary complex model.
@en
P2093
P304
P31
P407
P433
P478
P577
P698